These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15592687

  • 1. Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees.
    Farnham JM, Camp NJ, Swensen J, Tavtigian SV, Albright LA.
    Hum Genet; 2005 Feb; 116(3):179-85. PubMed ID: 15592687
    [Abstract] [Full Text] [Related]

  • 2. Genomic search for prostate cancer predisposition loci in Utah pedigrees.
    Camp NJ, Farnham JM, Cannon Albright LA.
    Prostate; 2005 Dec 01; 65(4):365-74. PubMed ID: 16037989
    [Abstract] [Full Text] [Related]

  • 3. Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees.
    Camp NJ, Farnham JM, Cannon-Albright LA.
    Cancer Res; 2006 Oct 15; 66(20):10205-12. PubMed ID: 17047086
    [Abstract] [Full Text] [Related]

  • 4. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
    Cancel-Tassin G, Latil A, Valéri A, Mangin P, Fournier G, Berthon P, Cussenot O.
    Eur J Hum Genet; 2001 Feb 15; 9(2):135-42. PubMed ID: 11313747
    [Abstract] [Full Text] [Related]

  • 5. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
    Lange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME, Cooney KA.
    Clin Cancer Res; 1999 Dec 15; 5(12):4013-20. PubMed ID: 10632333
    [Abstract] [Full Text] [Related]

  • 6. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees.
    Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA.
    Prostate; 2007 May 01; 67(6):605-13. PubMed ID: 17299800
    [Abstract] [Full Text] [Related]

  • 7. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27.
    Kouprina N, Pavlicek A, Noskov VN, Solomon G, Otstot J, Isaacs W, Carpten JD, Trent JM, Schleutker J, Barrett JC, Jurka J, Larionov V.
    Genome Res; 2005 Nov 01; 15(11):1477-86. PubMed ID: 16251457
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.
    Brown WM, Lange EM, Chen H, Zheng SL, Chang B, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Xu J, Cooney KA.
    Br J Cancer; 2004 Jan 26; 90(2):510-4. PubMed ID: 14735201
    [Abstract] [Full Text] [Related]

  • 10. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
    Baffoe-Bonnie AB, Smith JR, Stephan DA, Schleutker J, Carpten JD, Kainu T, Gillanders EM, Matikainen M, Teslovich TM, Tammela T, Sood R, Balshem AM, Scarborough SD, Xu J, Isaacs WB, Trent JM, Kallioniemi OP, Bailey-Wilson JE.
    Hum Genet; 2005 Aug 26; 117(4):307-16. PubMed ID: 15906096
    [Abstract] [Full Text] [Related]

  • 11. Genetic linkage analysis of prostate cancer families to Xq27-28.
    Peters MA, Jarvik GP, Janer M, Chakrabarti L, Kolb S, Goode EL, Gibbs M, DuBois CC, Schuster EF, Hood L, Ostrander EA, Stanford JL.
    Hum Hered; 2001 Aug 26; 51(1-2):107-13. PubMed ID: 11096277
    [Abstract] [Full Text] [Related]

  • 12. Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.
    Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA.
    Prostate; 2007 Sep 15; 67(13):1456-64. PubMed ID: 17654497
    [Abstract] [Full Text] [Related]

  • 13. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
    Schleutker J, Matikainen M, Smith J, Koivisto P, Baffoe-Bonnie A, Kainu T, Gillanders E, Sankila R, Pukkala E, Carpten J, Stephan D, Tammela T, Brownstein M, Bailey-Wilson J, Trent J, Kallioniemi OP.
    Clin Cancer Res; 2000 Dec 15; 6(12):4810-5. PubMed ID: 11156239
    [Abstract] [Full Text] [Related]

  • 14. Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families.
    Bochum S, Paiss T, Vogel W, Herkommer K, Hautmann R, Haeussler J.
    Prostate; 2002 Jun 01; 52(1):12-9. PubMed ID: 11992616
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees.
    Neuhausen SL, Farnham JM, Kort E, Tavtigian SV, Skolnick MH, Cannon-Albright LA.
    Hum Mol Genet; 1999 Dec 01; 8(13):2437-42. PubMed ID: 10556291
    [Abstract] [Full Text] [Related]

  • 16. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
    Camp NJ, Farnham JM, Wong J, Christensen GB, Thomas A, Cannon-Albright LA.
    Cancer Epidemiol Biomarkers Prev; 2009 Apr 01; 18(4):1290-4. PubMed ID: 19336566
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
    Xu J, Zheng SL, Carpten JD, Nupponen NN, Robbins CM, Mestre J, Moses TY, Faith DA, Kelly BD, Isaacs SD, Wiley KE, Ewing CM, Bujnovszky P, Chang B, Bailey-Wilson J, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB.
    Am J Hum Genet; 2001 Apr 01; 68(4):901-11. PubMed ID: 11254448
    [Abstract] [Full Text] [Related]

  • 18. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
    Cunningham JM, McDonnell SK, Marks A, Hebbring S, Anderson SA, Peterson BJ, Slager S, French A, Blute ML, Schaid DJ, Thibodeau SN, Mayo Clinic, Rochester, Minnesota.
    Prostate; 2003 Dec 01; 57(4):335-46. PubMed ID: 14601030
    [Abstract] [Full Text] [Related]

  • 19. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci.
    Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Forman D, Oliver T, Einhorn L, McMaster M, Kramer J, Greene MH, Weber BL, Nathanson KL, Cortessis V, Easton DF, Bishop DT, Stratton MR, Rapley EA.
    Hum Mol Genet; 2006 Feb 01; 15(3):443-51. PubMed ID: 16407372
    [Abstract] [Full Text] [Related]

  • 20. Perspective: prostate cancer susceptibility genes.
    Simard J, Dumont M, Soucy P, Labrie F.
    Endocrinology; 2002 Jun 01; 143(6):2029-40. PubMed ID: 12021166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.